Showing results (1-10 of 774) with videos related to
Sort By:
Pageof 78
Nature Cell Biology|March 1, 2012
Secreted miRNAs suppress atherogenesisDaniel J Rader, Michael S ParmacekEndocrinology|May 22, 2002
Perspective: cardiovascular disease in the postgenomic era--lessons learned and challenges aheadJonathan A Epstein, Daniel J Rader, Michael S ParmacekCirculation. Cardiovascular Quality and Outcomes|January 13, 2018
Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public PayersJalpa A Doshi, Justin T Puckett, Michael S Parmacek, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PrescriptionsJalpa A Doshi, Pengxiang Li, Justin T Puckett, et al.The Journal of Clinical Investigation|August 20, 2009
MicroRNA-modulated targeting of vascular smooth muscle cellsMichael S ParmacekTransactions of the American Clinical and Climatological Association|June 6, 2008
Cardiac stem cells and progenitors: developmental biology and therapeutic challengesMichael S ParmacekCirculation Research|March 17, 2007
Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptationMichael S ParmacekCell|February 15, 2005
Pursuing cardiac progenitors: regeneration reduxMichael S Parmacek, Jonathan A EpsteinProgress in Cardiovascular Diseases|March 2, 2005
Biology of the troponin complex in cardiac myocytesMichael S Parmacek, R John SolaroCirculation Research|March 16, 2013
An epigenetic roadmap for cardiomyocyte differentiationMichael S Parmacek, Jonathan A EpsteinPageof 78